Articles tagged with "FDA"

FDA Approves Secukinumab for Children with Enthesitis-Related Arthritis & PsA

February 2, 2022 • By Michele B. Kaufman, PharmD, BCGP

FDA Authorizes New Long-Acting, Monoclonal Antibodies for Pre-exposure Prevention of COVID-19 in Certain Individuals

December 13, 2021 • By U.S. Food & Drug Administration

Considerations for Prescribing Avacopan for ANCA-Associated Vasculitis

October 27, 2021 • By Michele B. Kaufman, PharmD, BCGP

FDA Grants Octapharma 7-Year Market Exclusivity for Octagam 10%

September 15, 2021 • By Michele B. Kaufman, PharmD, BCGP

FDA Approves IVIG to Treat Adults with Dermatomyositis

August 17, 2021 • By Michele B. Kaufman, PharmD, BCGP

AbbVie, Lilly Face New Delays in FDA Approval for Expanded Use of Janus Kinase Inhibitors

July 26, 2021

14 Rheumatology Treatments Make Top 50 List of Drugs That Can Cause Anaphylaxis

April 15, 2021 • By Michele B. Kaufman, PharmD, BCGP

FDA Approves Tocilizumab to Treat Systemic Sclerosis-Associated ILD

March 25, 2021 • By Michele B. Kaufman, PharmD, BCGP

FDA Approves Belimumab & Voclosporin for Lupus Nephritis

March 24, 2021 • By Michele B. Kaufman, PharmD, BCGP

Health Canada Approves CT-P13 SC for RA; Plus Tofacitinib May Increase Cardiac & Cancer Risks

March 5, 2021 • By Michele B. Kaufman, PharmD, BCGP

1
2
3
…
27
Next Page »